Sign in
Active, not recruitingNo phase

MORA Cure for Knee Osteoarthritis With Anterior Knee Pain

Key facts

Who runs it
EverEx Inc.
Where
South Korea2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
44 people, planned
Started
10 Jul 2026
Expected to end
28 Feb 2027
Type of study
Interventional
Treatments tested
  • MORA Cure
Record updated
18 August 2026

Who can take part

Age
51 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adults older than 50 years
  • Kellgren-Lawrence grade 1 or higher on weight-bearing plain radiographs of the study knee
  • Osteoarthritis-related pain in the study knee for at least 3 months
  • Anterior knee pain in the study knee involving the peripatellar, anterior patellar, or retropatellar region, with clear provocation or worsening of anterior knee pain during at least one patellofemoral joint-loading activity: stair ascent or descent, squatting, or rising from a chair
  • If medial, lateral, or posterior knee pain is also present, the participant is able to distinguish and separately report anterior knee pain
  • Voluntary written informed consent before study participation

Who cannot take part

  • Acute injury of the study knee within the previous 3 months, including fracture, ligament tear, or meniscal tear requiring surgical treatment or immobilization
  • Injection therapy to the study knee within the previous 3 months
  • Acute attack of gout or pseudogout in the study knee within the previous 3 months
  • Previous total knee arthroplasty, corrective osteotomy, or other major surgery affecting knee alignment or joint structure in the study knee
  • Any other condition that, in the investigator's judgment, makes the participant unsuitable for the study
  • Current use of opioid analgesics for pain control
  • Does not own a smartphone or is unable to use the mobile application
  • Current participation in another clinical trial or planned participation in another clinical trial during this study
  • Diagnosed active inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, or reactive arthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective, multicenter, single-arm, sponsor-initiated pilot study will evaluate the clinical course and safety of MORA Cure in adults older than 50 years with knee osteoarthritis accompanied by anterior knee pain. Participants will use MORA Cure for 8 weeks. MORA Cure provides personalized rehabilitation exercises and cognitive behavioral therapy-based content through a patient mobile application supported by a clinician web portal. Clinical outcomes will be assessed at baseline, Week 4, and Week 8. The planned enrollment is 44 participants at two sites in the Republic of Korea.

The group in the trial

  • Experimental: MORA CureTreatment being tested

    Participants will use MORA Cure for 8 weeks. Personalized rehabilitation exercises are performed at least 3 times per week for approximately 30 minutes per session, and cognitive behavioral therapy content is completed according to weekly sessions.

    Treatment: MORA Cure

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Multicenter, Single-Arm, Pilot Study to Evaluate the Clinical Outcomes and Safety of the Digital Therapeutic MORA Cure in Patients With Knee Osteoarthritis Accompanied by Anterior Knee Pain: 8-week
Record updated
18 August 2026